Mereo BioPharma Group (MREO)
NASDAQ: MREO
· Real-Time Price · USD
1.73
0.00 (0.00%)
At close: Sep 04, 2025, 3:59 PM
1.73
0.00%
Pre-market: Sep 05, 2025, 07:27 AM EDT
Mereo BioPharma Revenue Breakdown
| Period Ending | Jun 30, 2025 |
|---|---|
| Operating Segments Revenue | 500K |
| Operating Segments Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 5.49M | 7.27M | 6.45M | 6.2M | 7.87M | 5.91M | 3.6M | 2.78M | 11.28M | 4.77M | 12.21M | 7.28M | 10.89M | 5.81M | 9.37M | 4.89M | 11.68M | 5.98M | 16.23M | 8.39M | 2.91M | 5.1M | 10.82M | 5.31M | 7.42M | 4.51M | 4.38M | 4.48M | 3.23M | 3.44M | 3.82M | 3.79M | 3.28M | 3.16M | 2.92M | 2.9M | 4.66M | 5.05M |
| Selling, General, and Administrative Revenue Growth | -24.45% | +12.67% | +4.05% | -21.16% | +33.22% | +64.19% | +29.60% | -75.39% | +136.20% | -60.89% | +67.69% | -33.18% | +87.62% | -38.05% | +91.60% | -58.13% | +95.45% | -63.17% | +93.35% | +188.84% | -43.07% | -52.81% | +103.74% | -28.46% | +64.76% | +2.83% | -2.18% | +38.46% | -5.93% | -9.94% | +0.77% | +15.43% | +3.96% | +8.30% | +0.40% | -37.67% | -7.70% | n/a |
| Research and Development Revenue | 5.37M | 3.93M | 8.82M | 3.17M | 4.95M | 3.99M | 2.89M | 3.19M | 9.74M | 3.95M | 13.67M | 6.55M | 17.27M | 8.75M | 18.67M | 9.23M | 13.69M | 6.79M | 10.27M | 5.08M | 4.24M | 5.27M | 14.71M | 7.19M | 15.42M | 7.76M | 7.55M | 7.71M | 7.17M | 7.62M | 8.91M | 8.84M | 13.94M | 13.41M | 8.28M | 8.71M | 7.39M | 8.01M |
| Research and Development Revenue Growth | +36.72% | -55.45% | +178.26% | -35.91% | +23.84% | +38.40% | -9.49% | -67.26% | +146.64% | -71.11% | +108.80% | -62.09% | +97.35% | -53.13% | +102.24% | -32.57% | +101.49% | -33.86% | +102.39% | +19.73% | -19.57% | -64.18% | +104.74% | -53.39% | +98.67% | +2.85% | -2.18% | +7.60% | -5.93% | -14.46% | +0.77% | -36.57% | +3.96% | +61.93% | -4.94% | +17.85% | -7.70% | n/a |